Oral Answers to Questions

Preet Kaur Gill Excerpts

Wednesday 29th April 2020 Commons Chamber

[Anne-Marie Trevelyan]

Coronavirus is a global crisis that knows no borders and will have a profound effect on all countries, including the most vulnerable. That is why the UK is leading the international response and providing £744 million of UK aid to counter the health, humanitarian and economic impacts. I have mobilised my Department and our country offices to do whatever it takes to help tackle this pandemic and the secondary risks. We have the funding, the expertise and the British determination to stand by our friends in developing countries to prevent a second wave of infection.

[Preet Kaur Gill (Birmingham, Edgbaston) (Lab/Co-op) [V]]

During the coronavirus pandemic, it is imperative that countries and communities engage co-operatively with one another to avoid a scramble to procure goods, personal protective equipment and medical equipment and ensure that there is not a worldwide shortage that prices out the world’s most vulnerable. In the light of the announcement made by the President of the United States about ending funding to the World Health Organisation, can the Secretary of State outline what representations she and her Government have made to him regarding the need to follow collaborative principles, which will benefit us all?

[Anne-Marie Trevelyan]

The UK has confidence in the WHO and the work that it is doing globally to bring together every country to do the best they can to look after their communities and citizens. The WHO is co-ordinating PPE for all those countries, and we are supporting it by putting funding into the central pot, so that it can ensure that the countries that are most in need will have the PPE that they require.

--- Later in debate ---

[Wendy Morton]

My hon. Friend is right to recognise that international co-operation is absolutely vital to tackle covid-19. That is why we are working with the WHO and other international organisations to develop and deliver a globally accessible vaccine, alongside effective tests and treatments, and because of this we want to ensure they are safe, effective, affordable and accessible for all, including the world’s poorest.

[Preet Kaur Gill (Birmingham, Edgbaston) (Lab/Co-op) [V]]

This week is World Immunisation Week. Every year millions of lives are saved thanks to immunisations, and it is recognised widely as one of the most successful and cost-effective health interventions. With DFID funding going into the global effort to tackle this health crisis, can the Secretary of State explain what safeguards she has implemented to ensure that UK public contributions to the research into and development of covid-19 diagnostics, treatments and vaccines will be guaranteed to every person, and to assure the British public that public money is not just going into lining the pockets of big pharmaceutical companies?

[Wendy Morton]

Of course, while we are focusing on covid-19, there is the broader issue of vaccines. The UK is already one of the biggest global donors. To date, we have pledged £744 million to support the international response to covid-19. We have also funded £40 million for the Wellcome and Mastercard therapeutics accelerator initiative, up to £23 million for the Foundation for Innovative New Diagnostics, and up to £5 million through the joint initiative on research for epidemic preparedness. Because we are faced with a global pandemic, we absolutely need an international response, and it is about making sure that vaccines reach all those who need them.